Company intelligence / Profile preview

Tabuk Pharmaceuticals

Riyadh, Riyadh, Saudi Arabiatabukpharmaceuticals.com ↗

Ownership: Private
Employees: ~2400
Development stage: Commercial

Overview

Tabuk Pharmaceuticals is the largest privately-owned pharmaceutical company in Saudi Arabia. It develops, manufactures, markets, and distributes branded generics as well as partners with international companies for contract manufacturing. The company has a strong R&D focus on multiple therapeutic areas including cardiovascular, respiratory, CNS, musculoskeletal and gastrointestinal systems. It operates four advanced manufacturing sites across Saudi Arabia (Tabuk & Dammam), Sudan and Algeria. Recent clinical/commercial highlights include partnerships to commercialize GLP‑1 analogs for diabetes/weight management with Biocon and a ustekinumab biosimilar with Bio-Thera Solutions.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularRheumatologyEndocrinologyImmunologyNeurologyInfectious Diseases
Modalities: Small molecules (branded and generic drugs)Biosimilars (e.g., ustekinumab biosimilar partnership with Bio-Thera Solutions)Peptides/GLP‑1 analogs (via Biocon partnership for diabetes and weight management products)
Industry: Biotech

Drug pipeline

1 asset

BAT2206

Pre-registration

Indications: Crohn's disease, Ulcerative colitis, Plaque psoriasis, Psoriatic arthritis

Partnerships

Biocon Ltd – licensing/supply agreement for GLP‑1 products for diabetes & chronic weight mgmt in MENA regionBio-Thera Solutions – commercialization of BAT2206 ustekinumab biosimilarKing Saud University – academic collaboration/MoU for training/research

Beyond the preview

Go deeper on Tabuk Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tabuk Pharmaceuticals.

Explore the full profile